Research & Innovation 2022 - Innovations for tomorrow’s drug discovery

Presentation

Tue 29 March

30 March

[Schedule with Sessions only]

DAY 1

The Thames Hall

The Cherwell

DAY 2

DAY 1

The Thames Hall

The Cherwell

DAY 2

9:00

Registration & Refreshments
09:00 (70 mins)

9:00:

9:05:

9:10:

9:15:

9:20:

9:25:

9:30:

9:35:

9:40:

9:45:

9:50:

9:55:

10:00

10:05

10:10

Omics technology innovations

Session Introduction
10:10 (5 mins)
Alex Gutteridge, Enedra Therapeutics Ben Sidders, AstraZeneca

The hottest trends in genomics
10:15 (30 mins)
James Hadfield, AstraZeneca

LabLogic Life Sciences range has something for everyone.
10:45 (5 mins)
Lucy Farmer — LabLogic Systems Limited

Discover the proteome with CETSA® Explore
10:50 (5 mins)
Jakub Lewicki — Pelago Bioscience AB

Identifying causal biology for therapeutic intervention using genetics and genomics
10:55 (30 mins)
Dan Gaffney, Genomics PLC

The future of therapeutic genome engineering

Session Introduction
10:10 (5 mins)
Alasdair Russell, CRUK Cambridge Institute University of Cambridge John Lambourne, Transine Therapeutics

Pin-pointTM: Versatile Editing Platform Driving Cell Therapies
10:15 (30 mins)
Immacolata Porreca, Horizon Discovery

Endogenous protein tagging using CRISPR genome editing – applications for small-molecule and therapeutic antibody drug discovery
10:45 (5 mins)
Craig Malcolm — Promega UK Ltd

The VANTAstar™, a new compact flexible instrument with ease of use at its core.
10:50 (5 mins)
Catherine Wark — BMG LABTECH Ltd

The potential of mitochondrial genome engineering for therapies
10:55 (30 mins)
Pedro Silva-Pinheiro, MRC

10:10

10:15

10:20

10:25

10:30

10:35

10:40

10:45

10:50

10:55

11:00

11:05

11:10

11:15

11:20

11:25

Refreshment Break

11:25

11:30

11:35

11:40

11:45

11:50

11:55

Omics technology innovations

The Evolving Role of Functional Genomics in Oncology Drug Discovery
11:55 (30 mins)
Fiona Behan, GlaxoSmithKline

Assist Plus Pipetting Platform
12:25 (5 mins)
Sharon Barnard — INTEGRA Bioscience Ltd

Applying an integrated approach in clinical trials to identify and validate biomarker signature predicting response to therapeutics
12:30 (30 mins)
Maggie Chon U Cheang, THE INSTITUTE OF CANCER RESEARCH

The future of therapeutic genome engineering

Base editors: development and application
11:55 (30 mins)
Holly Rees, Beam Therapeutics

Pressure over liquid – Established technology but with new value
12:25 (5 mins)
Paul Kendall — FESTO

Track Panel Discussion
11:55 (30 mins)
Alasdair Russell, CRUK Cambridge Institute University of Cambridge Immacolata Porreca, Horizon Discovery Pedro Silva-Pinheiro, MRC Holly Rees, Beam Therapeutics

11:55

12:00

12:05

12:10

12:15

12:20

12:25

12:30

12:35

12:40

12:45

12:50

12:55

1:00

Refreshment Break

1:00:

1:05:

1:10:

1:15:

1:20:

1:25:

1:30:

1:35:

1:40:

1:45:

1:50:

1:55:

2:00

2:00:

2:05:

2:10:

2:15:

Omics technology innovations

Using large-scale genomics to improve drug development
14:15 (30 mins)
Oliver Burren, AstraZeneca

Powerful, open and fully automated: Ultra-high content imaging with the MACSima™ Imaging Platform
14:45 (15 mins)
Simon Bennett — Miltenyi Biotec

Genomic and digital pathology approaches to elucidate cancer cell quiescence
15:00 (30 mins)
Maria Secrier, University College London

The future of therapeutic genome engineering

New molecular technologies for genome editing and cell control
14:15 (40 mins)
Omar Abudayyeh , MIT Jonathan Gootenberg, McGovern Institute for Brain Research, MIT

TBC
14:55 (5 mins)
Omoleye Coker — Cellbox Solutions

2:15:

2:20:

2:25:

2:30:

2:35:

2:40:

2:45:

2:50:

2:55:

3:00

3:00:

3:05:

3:10:

3:15:

3:20:

3:25:

3:30:

Refreshment Break

3:30:

3:35:

3:40:

3:45:

3:50:

3:55:

4:00

Welcome to ELRIG

Chairs: Melanie Leveridge, GSK

4:00:

4:05:

Early Career Professional Impact Award : Sponsored by Sengenics

Chairs: Mark Soave, Omass

From GWAS to Causal Genes: A CRISPR Screen for Type 2 Diabetes
16:05 (20 mins)
Antje Grotz, AstraZeneca

4:05:

4:10:

4:15:

4:20:

4:25:

4:30:

Platinum Sponsorship Presentation

End-to-end automation: driving efficiency and reproducibility for drug discovery
16:30 (30 mins)
Gareth Fearnley — Nexcelom from PerkinElmer

4:30:

4:35:

4:40:

4:45:

4:50:

4:55:

5:00

Keynote Presentation

Transformative genome-edited therapies for patients
17:00 (45 mins)
Rachel Haurwitz, Caribou Biosciences

5:00:

5:05:

5:10:

5:15:

5:20:

5:25:

5:30:

5:35:

5:40:

5:45:

Networking and Drinks Reception
17:45 (75 mins)

5:45:

5:50:

5:55:

6:00

6:00:

6:05:

6:10:

6:15:

6:20:

6:25:

6:30:

6:35:

6:40:

6:45:

6:50:

6:55:

7:00

7:00: